An issue of Acadia Healthcare Co. (NASDAQ:ACHC) debt fell 1.3% as a percentage of its face value during trading on Wednesday after Royal Bank Of Canada lowered their price target on the stock from $78.00 to $59.00. The debt issue has a 6.5% coupon and will mature on March 1, 2024. The debt is now trading at $103.50. Price changes in a company’s debt in credit markets sometimes predict parallel changes in its share price.

Other equities research analysts have also issued research reports about the stock. Jefferies Group reaffirmed a “buy” rating and set a $85.00 target price on shares of Acadia Healthcare in a research note on Monday, June 27th. Leerink Swann reaffirmed a “buy” rating and set a $80.00 target price on shares of Acadia Healthcare in a research note on Sunday, August 28th. Zacks Investment Research raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, October 3rd. JPMorgan Chase & Co. reaffirmed a “hold” rating and set a $61.00 target price on shares of Acadia Healthcare in a research note on Tuesday, September 27th. Finally, Robert W. Baird cut their target price on shares of Acadia Healthcare from $67.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, September 15th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Acadia Healthcare presently has an average rating of “Buy” and a consensus price target of $75.86.

In other Acadia Healthcare news, major shareholder Waud Capital Partners Iii, L.L sold 457,443 shares of Acadia Healthcare stock in a transaction dated Friday, September 16th. The shares were sold at an average price of $48.39, for a total value of $22,135,666.77. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Ronald Morgan Fincher sold 8,800 shares of Acadia Healthcare stock in a transaction dated Monday, August 8th. The stock was sold at an average price of $52.56, for a total transaction of $462,528.00. Following the completion of the transaction, the chief operating officer now directly owns 120,780 shares of the company’s stock, valued at $6,348,196.80. The disclosure for this sale can be found here. 17.20% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Aperio Group LLC boosted its position in Acadia Healthcare by 39.2% in the first quarter. Aperio Group LLC now owns 6,032 shares of the company’s stock valued at $332,000 after buying an additional 1,699 shares during the last quarter. Prudential Financial Inc. boosted its position in Acadia Healthcare by 98.2% in the first quarter. Prudential Financial Inc. now owns 94,340 shares of the company’s stock valued at $5,199,000 after buying an additional 46,750 shares during the last quarter. BlackRock Fund Advisors boosted its position in Acadia Healthcare by 16.6% in the first quarter. BlackRock Fund Advisors now owns 776,809 shares of the company’s stock valued at $42,810,000 after buying an additional 110,692 shares during the last quarter. BlackRock Institutional Trust Company N.A. boosted its position in Acadia Healthcare by 23.7% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 1,657,465 shares of the company’s stock valued at $91,343,000 after buying an additional 317,107 shares during the last quarter. Finally, State Street Corp boosted its position in Acadia Healthcare by 30.4% in the first quarter. State Street Corp now owns 890,807 shares of the company’s stock valued at $49,096,000 after buying an additional 207,605 shares during the last quarter.

The company has a market capitalization of $3.53 billion, a PE ratio of 21.59 and a beta of 0.86. The firm’s 50-day moving average is $49.05 and its 200-day moving average is $54.52.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Friday, July 29th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. Acadia Healthcare had a net margin of 6.44% and a return on equity of 9.35%. The company had revenue of $756.50 million for the quarter, compared to analysts’ expectations of $752.57 million. During the same period in the prior year, the business earned $0.57 EPS. The firm’s quarterly revenue was up 66.8% on a year-over-year basis. Equities analysts anticipate that Acadia Healthcare Co. will post $2.63 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.

5 Day Chart for NASDAQ:ACHC

Receive News & Stock Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related stocks with our FREE daily email newsletter.